Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Synthetic antigenic peptides and lipopeptides derived from Mycobacterium avium subsp. paratuberculosis

Synthetic antigenic peptides and lipopeptides derived from Mycobacterium avium subsp. paratuberculosis

US Patent 8883173 · Granted Nov 11, 2014

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Antigenic tripeptides derived from Mycobacterium avium subsp. paratuberculosis S2025
Antigenic tripeptides derived from Mycobacterium avium subsp. paratuberculosis S2025
Antigenic tripeptides derived from Mycobacterium avium subsp. paratuberculosis s2024
Antigenic tripeptides derived from Mycobacterium avium subsp. paratuberculosis s2024
Antigenic tripeptides derived from Mycobacterium avium subsp. paratuberculosis s2022
Antigenic tripeptides derived from Mycobacterium avium subsp. paratuberculosis s2022
Camelid single-domain antibody directed against phosphorylated tau proteins and 2021
CD31 shed as a molecular target for imaging of inflammation2021
Method for preparing multiple antigen glycopeptide carbohydrate conjugates2021
Oligopeptide and methods for producing conjugates thereof2020
Camelid single-domain antibody directed against phosphorylated tau proteins and 2020
Camelid single-domain antibody directed against phosphorylated tau proteins and 2018